Sustained Improvements In Health-Related Quality Of Life In Patients With Systemic Lupus Erythematosus Following Epratuzumab TreatmentResults From A Phase Iib Study And Its Open-Label Extension
Abstract
Authors
V Strand J Merrill E Nikai B Kilgallen A Regnault C Gordon